Results 161 to 170 of about 1,481 (180)

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment

International Journal of Neuropsychopharmacology, 2020
Markus Dold, Lucie Bartova, Siegfried Kasper   +2 more
exaly  

US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior

Journal of Comparative Effectiveness Research, 2022
Jennifer Voelker
exaly  

Esketamine nasal spray too costly for treatment-resistant depression

PharmacoEconomics & Outcomes News, 2020
openaire   +1 more source

Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed

Journal of Affective Disorders, 2020
Leslie Citrome
exaly  

Cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the US utilizing clinical trial efficacy and real-world effectiveness estimates

Journal of Affective Disorders, 2022
Madeline Brendle, Daniel C Malone
exaly  

Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3

American Journal of Geriatric Psychiatry, 2020
David Hough, Husseini K Manji, Gerard Sanacora   +2 more
exaly  

233. Transcriptional Profiling of Peripheral Blood in Depressive Patients Treated With Esketamine Nasal Spray

Biological Psychiatry, 2023
Qingqin Li, Chun Wu, Nabil Azhar, Vanina Popova, Maggie Fedgchin, Dong-Jing Fu, Carla Canuso, Wayne C. Drevets   +7 more
openaire   +1 more source

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression

JAMA Psychiatry, 2019
Madhukar Trivedi, Xiang Li, David Hough
exaly  

Esketamine nasal spray effective for rapid improvement of depressive symptoms

Clinical Pharmacist, 2019
openaire   +2 more sources

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

American Journal of Psychiatry, 2019
Vanina Popova, Madhukar Trivedi, David Hough   +2 more
exaly